BR0210342A - Goma de mascar revestida contendo nicotina e fabricação e uso da mesma - Google Patents
Goma de mascar revestida contendo nicotina e fabricação e uso da mesmaInfo
- Publication number
- BR0210342A BR0210342A BR0210342-7A BR0210342A BR0210342A BR 0210342 A BR0210342 A BR 0210342A BR 0210342 A BR0210342 A BR 0210342A BR 0210342 A BR0210342 A BR 0210342A
- Authority
- BR
- Brazil
- Prior art keywords
- nicotine
- coated
- chewing gum
- manufacture
- forms
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
- A23B4/00—General methods for preserving meat, sausages, fish or fish products
- A23B4/10—Coating with a protective layer; Compositions or apparatus therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/02—Apparatus specially adapted for manufacture or treatment of chewing gum
- A23G4/04—Apparatus specially adapted for manufacture or treatment of chewing gum for moulding or shaping
- A23G4/043—Apparatus specially adapted for manufacture or treatment of chewing gum for moulding or shaping for composite chewing gum
- A23G4/046—Apparatus specially adapted for manufacture or treatment of chewing gum for moulding or shaping for composite chewing gum with a centre made of chewing gum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
- A23G4/126—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/18—Chewing gum characterised by shape, structure or physical form, e.g. aerated products
- A23G4/20—Composite products, e.g. centre-filled, multi-layer, laminated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Physiology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Confectionery (AREA)
Abstract
"GOMA DE MASCAR REVESTIDA CONTENDO NICOTINA E FABRICAçãO E USO DA MESMA". A presente invenção se refere a um produto de goma de mascar revestida para liberação de nicotina em quaisquer de suas formas a uma pessoa, mediante rápida absorção transmucosal na cavidade oral, compreendendo pelo menos um núcleo de goma, nicotina em quaisquer de suas formas e/ou um agente imitativo de nicotina, pelo menos uma camada de revestimento e, opcionalmente, pelo menos um ou mais aditivos, em que a dita pelo menos uma camada de revestimento é tamponada. A invenção também contempla um método para a liberação de nicotina em quaisquer de suas formas, um método para redução da ansiedade de fumar ou de utilizar o fumo, assim como, um método para produzir a dita goma de mascar revestida e o uso da mesma, de modo a se obter uma rápida absorção transmucosal da nicotina na cavidade oral de uma pessoa.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0102197A SE0102197D0 (sv) | 2001-06-20 | 2001-06-20 | New product and use and manufacture thereof |
PCT/SE2002/001158 WO2002102357A1 (en) | 2001-06-20 | 2002-06-14 | A coated nicotine-containing chewing gum, manufacture and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0210342A true BR0210342A (pt) | 2004-07-13 |
Family
ID=20284551
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0210342-7A BR0210342A (pt) | 2001-06-20 | 2002-06-14 | Goma de mascar revestida contendo nicotina e fabricação e uso da mesma |
Country Status (19)
Country | Link |
---|---|
US (2) | US20040194793A1 (pt) |
EP (1) | EP1404306B1 (pt) |
JP (2) | JP4571402B2 (pt) |
AR (1) | AR034527A1 (pt) |
AT (1) | ATE485034T1 (pt) |
AU (1) | AU2002345454B2 (pt) |
BR (1) | BR0210342A (pt) |
CA (1) | CA2449298C (pt) |
CZ (1) | CZ20033458A3 (pt) |
DE (1) | DE60238054D1 (pt) |
DK (1) | DK1404306T3 (pt) |
ES (1) | ES2352681T3 (pt) |
IL (2) | IL159425A0 (pt) |
MX (1) | MXPA03011557A (pt) |
NZ (1) | NZ529780A (pt) |
RU (1) | RU2291688C2 (pt) |
SE (1) | SE0102197D0 (pt) |
WO (1) | WO2002102357A1 (pt) |
ZA (1) | ZA200309204B (pt) |
Families Citing this family (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004056363A2 (en) | 2002-12-20 | 2004-07-08 | Niconovum Ab | A physically and chemically stable nicotine-containing particulate material |
SE0302947D0 (sv) | 2003-01-24 | 2003-11-07 | Magle Ab | A composition material for transmucosal delivery |
SI1617823T1 (sl) * | 2003-01-24 | 2019-07-31 | Nicachet Ab | Vrečka, ki obsega nikotinski sestavek za transmukozno dajanje |
ES2291621T5 (es) * | 2003-02-04 | 2012-11-08 | Gumlink A/S | Pastilla de goma de mascar comprimida |
EP1449525A1 (en) * | 2003-02-20 | 2004-08-25 | Cross Chem Llc | chewing gum in the form of multi-layer tablets |
WO2006000233A1 (en) * | 2004-06-29 | 2006-01-05 | Fertin Pharma A/S | Tobacco alkaloid containing chewing gum |
AU2005272802B2 (en) * | 2004-08-11 | 2009-07-02 | Intercontinental Great Brands Llc | Sensate compositions and delivery systems therefor |
US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
JP5254616B2 (ja) | 2004-09-13 | 2013-08-07 | クロノ セラピューティクス、インコーポレイテッド | 生物学的同調性(biosynchronous)経皮的薬物送達 |
MX2007004045A (es) | 2004-10-08 | 2007-06-07 | Gumlink As | Producto de confiteria. |
WO2006058536A1 (en) | 2004-11-30 | 2006-06-08 | Fertin Pharma A/S | Method of providing fast relief to a user of a nicotine chewing gum |
US8323683B2 (en) | 2005-05-18 | 2012-12-04 | Mcneil-Ppc, Inc. | Flavoring of drug-containing chewing gums |
US8709502B2 (en) * | 2005-09-23 | 2014-04-29 | Chanel Parfums Beaute | Extract of Vanilla planifolia |
US8024911B2 (en) | 2006-02-16 | 2011-09-27 | Mcneil Ab | Method for blister packing |
CA2646942C (en) | 2006-03-16 | 2014-07-29 | Niconovum Ab | Improved snuff composition |
AU2007224586A1 (en) * | 2006-03-16 | 2007-09-20 | Niconovum Ab | Stable lozenge compositions providing rapid release of nicotine |
US20070269386A1 (en) | 2006-05-16 | 2007-11-22 | Per Steen | New product and use and manufacture thereof |
US20070269492A1 (en) * | 2006-05-16 | 2007-11-22 | Per Steen | New product and use and manufacture thereof |
AU2012241150B2 (en) * | 2006-07-21 | 2015-04-16 | Jsrnti, Llc | Medicinal delivery system and related methods |
US8642016B2 (en) | 2006-07-21 | 2014-02-04 | Jsrnti, Llc | Medicinal delivery system, and related methods |
NZ579205A (en) * | 2007-02-26 | 2012-03-30 | Revolymer Ltd | Chewing gum containing an amphiphilic polymer which controls the release of a drug or other biologically active material |
EP2322166A1 (en) * | 2007-04-02 | 2011-05-18 | Parkinson's Institute | Methods and compositions for reduction of side effects of therapeutic treatments |
US20080286340A1 (en) * | 2007-05-16 | 2008-11-20 | Sven-Borje Andersson | Buffered nicotine containing products |
US20080286341A1 (en) * | 2007-05-16 | 2008-11-20 | Sven-Borje Andersson | Buffered coated nicotine containing products |
EP2197430A2 (en) * | 2007-09-18 | 2010-06-23 | NicoNovum AB | Stable chewing gum compositions comprising maltitol and providing rapid release of nicotine |
JP2009102287A (ja) * | 2007-10-19 | 2009-05-14 | Seiji Sakao | 禁煙用の辛い唐辛子 |
EP2229156B1 (en) | 2007-12-20 | 2016-11-09 | Fertin Pharma A/S | Chewing gum tablet and method of dosing pharmaceutically active ingredients in such chewing gum tablet |
WO2009080021A1 (en) | 2007-12-20 | 2009-07-02 | Fertin Pharma A/S | Compressed chewing gum tablet |
EP2229158B1 (en) | 2007-12-20 | 2016-08-10 | Fertin Pharma A/S | Compressed chewing gum tablet |
AR071420A1 (es) | 2008-05-01 | 2010-06-16 | Smithkline Beecham Corp | Composicion de pastilla para chupar oral que comprende un principio activo de nicotina y procedimiento para fabricarla |
RU2501551C2 (ru) * | 2008-05-21 | 2013-12-20 | Новартис Аг | Таблетируемые жевательные резинки |
EP2282645B1 (en) | 2008-05-26 | 2015-04-15 | Fertin Pharma A/S | Flavor impregnation of a chewing gum core |
US9700525B2 (en) | 2008-08-20 | 2017-07-11 | Board Of Supervisors Of Louisiana State University And Agricultural & Mechanical College | Continuous local slow-release of therapeutics for head and neck problems and upper aerodigestive disorders |
CA2736531C (en) * | 2008-09-17 | 2016-10-25 | Niconovum Ab | Process for preparing snuff composition |
AU2009303979A1 (en) * | 2008-10-14 | 2010-04-22 | Mcneil Ab | Multi portion intra-oral dosage form and use thereof |
US8506936B2 (en) * | 2008-11-25 | 2013-08-13 | Watson Laboratories, Inc. | Stabilized nicotine chewing gum |
EP2373179B1 (en) | 2008-12-19 | 2018-08-01 | Fertin Pharma A/S | Multi-part kit comprising a chewing gum and further a flavor containing formulation |
US9307787B2 (en) * | 2008-12-19 | 2016-04-12 | U.S. Smokeless Tobacco Company Llc | Tobacco granules and method of producing tobacco granules |
EP2233134A1 (en) * | 2009-03-27 | 2010-09-29 | McNeil AB | Multi-portion intra-oral dosage form with organoleptic properties |
WO2010145653A1 (en) | 2009-06-19 | 2010-12-23 | Fertin Pharma A/S | Buffered gum base for high ph release |
RU2417095C1 (ru) * | 2010-02-12 | 2011-04-27 | Александр Ицхокович Кашлинский | Средство "куримало" ("км"), снижающее тягу к курению |
US20110268809A1 (en) | 2010-04-28 | 2011-11-03 | Paul Andrew Brinkley | Nicotine-Containing Pharmaceutical Compositions |
US20110274628A1 (en) | 2010-05-07 | 2011-11-10 | Borschke August J | Nicotine-containing pharmaceutical compositions |
US8529914B2 (en) * | 2010-06-28 | 2013-09-10 | Richard C. Fuisz | Bioactive dose having containing a material for modulating pH of a bodily fluid to help or hinder absorption of a bioactive |
US20130017259A1 (en) | 2011-07-06 | 2013-01-17 | The Parkinson's Institute | Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients |
WO2013056709A1 (en) * | 2011-10-19 | 2013-04-25 | Fertin Pharma A/S | Nicotine chewing gum with improved utilization of nicotine |
US9907748B2 (en) | 2011-10-21 | 2018-03-06 | Niconovum Usa, Inc. | Excipients for nicotine-containing therapeutic compositions |
US20130177646A1 (en) * | 2012-01-05 | 2013-07-11 | Mcneil Ab | Solid Nicotine-Comprising Dosage Form with Reduced Organoleptic Disturbance |
US10130120B2 (en) | 2013-03-15 | 2018-11-20 | Altria Client Services Llc | Use of pectin or other anionic polymers in the stabilization and controlled release of nicotine in oral sensorial tobacco products or nicotine containing non-tobacco oral sensorial products |
CN105530825A (zh) * | 2013-07-19 | 2016-04-27 | 奥驰亚客户服务有限责任公司 | 电子吸烟器具的液体气溶胶制剂 |
CN103478893B (zh) * | 2013-09-09 | 2016-02-10 | 湖南中烟工业有限责任公司 | 茶氨酸在胶基咀嚼型无烟气烟草制品中的应用 |
JP6682450B2 (ja) | 2014-04-08 | 2020-04-15 | フェルティン ファルマ アー/エス | 医療用チューインガム |
US9744128B2 (en) | 2014-06-05 | 2017-08-29 | Mastix LLC | Method for manufacturing medicated chewing gum without cooling |
CA2974324A1 (en) | 2015-01-28 | 2016-08-04 | Zita S. Netzel | Drug delivery methods and systems |
WO2016145373A1 (en) | 2015-03-12 | 2016-09-15 | Chrono Therapeutics Inc. | Craving input and support system |
US20170165252A1 (en) | 2015-12-10 | 2017-06-15 | Niconovum Usa Inc. | Protein-enriched therapeutic composition |
EP3445344B1 (en) | 2016-04-21 | 2020-08-19 | Fertin Pharma A/S | Nicotine delivery product, related uses and oral dosage forms, and methods of production |
US10765658B2 (en) | 2016-06-22 | 2020-09-08 | Mastix LLC | Oral compositions delivering therapeutically effective amounts of cannabinoids |
US10632076B2 (en) | 2016-11-18 | 2020-04-28 | Fertin Pharma A/S | Tablet comprising separate binder and erythritol |
US10543205B2 (en) | 2016-11-18 | 2020-01-28 | Fertin Pharma A/S | Oral delivery vehicle containing nicotine |
AU2018205529B2 (en) | 2017-01-06 | 2023-08-10 | Morningside Venture Investments Limited | Transdermal drug delivery devices and methods |
SE541358C2 (en) | 2017-05-30 | 2019-08-13 | Enorama Pharma Ab | Nicotine-containing chewing gum compositions |
US11135157B2 (en) | 2018-05-17 | 2021-10-05 | Fertin Pharma A/S | Oral tablet for delivery of active ingredients to the throat |
US11058633B2 (en) | 2018-05-17 | 2021-07-13 | Fertin Pharma A/S | Disintegrating oral tablet suitable for active pharmaceutical ingredients |
JP7214755B2 (ja) * | 2018-05-17 | 2023-01-30 | フェルティン ファルマ アー/エス | 医薬品活性成分に適した錠剤化チューインガム |
US11096896B2 (en) | 2018-05-17 | 2021-08-24 | Fertin Pharma A/S | Tablet dosage form for buccal absorption of active ingredients |
US20190350858A1 (en) | 2018-05-17 | 2019-11-21 | Fertin Pharma A/S | Oral tablet for delivery of active ingredients to the gastrointestinal tract |
US11058641B2 (en) | 2018-05-17 | 2021-07-13 | Fertin Pharma A/S | Oral tablet for taste masking of active ingredients |
US11096895B2 (en) * | 2018-05-17 | 2021-08-24 | Fertin Pharma A/S | Oral tablet suitable for active pharmaceutical ingredients |
US11052047B2 (en) | 2018-05-17 | 2021-07-06 | Fertin Pharma A/S | Oral tablet suitable for fast release of active pharmaceutical ingredients |
US11090263B2 (en) | 2018-05-22 | 2021-08-17 | Fertin Pharma A/S | Tableted chewing gum suitable for active pharmaceutical ingredients |
US11096894B2 (en) | 2018-05-17 | 2021-08-24 | Fertin Pharma A/S | Oral tablet for induced saliva generation |
JP7420797B2 (ja) | 2018-05-29 | 2024-01-23 | モーニングサイド ベンチャー インベストメンツ リミテッド | 薬剤送達の方法及びシステム |
CN112384504A (zh) | 2018-06-15 | 2021-02-19 | R.J.雷诺兹烟草公司 | 烟碱的纯化 |
EP3820456A1 (en) * | 2018-07-13 | 2021-05-19 | McNeil AB | Chewing gum comprising nicotine |
CN108991596B (zh) * | 2018-10-11 | 2020-07-28 | 玉溪开元金蓝生物科技有限责任公司 | 复方滇橄榄添加料、制备方法及其在香烟滤嘴棒上的应用 |
CN114945359A (zh) * | 2020-01-15 | 2022-08-26 | 麦克内尔股份公司 | 口香糖的产品和制备方法 |
WO2022224200A1 (en) * | 2021-04-22 | 2022-10-27 | Nicoventures Trading Limited | Oral compositions and methods of manufacture |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3877468A (en) | 1970-07-22 | 1975-04-15 | Leo Ab | Chewable tobacco substitute composition |
US3901248A (en) | 1970-07-22 | 1975-08-26 | Leo Ab | Chewable smoking substitute composition |
US3845217A (en) * | 1972-11-16 | 1974-10-29 | Helsingborg L Ab | Buffered smoking substitute compositions |
US4366211A (en) | 1981-09-21 | 1982-12-28 | Westinghouse Electric Corp. | Control of electrolyte fill to fuel cell stack |
GB8301659D0 (en) * | 1983-01-21 | 1983-02-23 | Leo Ab | Smoking substitutes |
US4920989A (en) * | 1985-04-25 | 1990-05-01 | Regents Of The University Of California | Method and apparatus for aiding in the reduction of incidence of tobacco smoking |
GB8615676D0 (en) * | 1986-06-26 | 1986-07-30 | Stoppers Co Ltd | Nicotine containing lozenge |
US5057328A (en) * | 1988-11-14 | 1991-10-15 | Warner-Lambert Company | Food acid delivery systems containing polyvinyl acetate |
US5154939A (en) * | 1989-04-19 | 1992-10-13 | Wm. Wrigley Jr. Company | Use of salt to improve extrusion encapsulation of chewing gum ingredients |
US5167242A (en) * | 1990-06-08 | 1992-12-01 | Kabi Pharmacia Aktiebolaq | Nicotine-impermeable container and method of fabricating the same |
GB9200047D0 (en) * | 1992-01-03 | 1992-02-26 | Univ Alberta | Nicotine-containing nasal spray |
US6024097A (en) * | 1992-02-20 | 2000-02-15 | J Mom Trust | Product for assisting a smoker in giving up the habit |
US5869505A (en) * | 1993-02-02 | 1999-02-09 | Keenan; Robert M. | Nicotine metabolites and nicotine dependence |
US5549906A (en) * | 1993-07-26 | 1996-08-27 | Pharmacia Ab | Nicotine lozenge and therapeutic method for smoking cessation |
US5362496A (en) * | 1993-08-04 | 1994-11-08 | Pharmetrix Corporation | Method and therapeutic system for smoking cessation |
SE9303574D0 (sv) * | 1993-11-01 | 1993-11-01 | Kabi Pharmacia Ab | Composition for drug delivery and method the manufacturing thereof |
GB2289204B (en) * | 1994-04-21 | 1998-01-14 | Williamson Research Limited | A chewing gum for use as a nicotine substitute and slimming aid |
US5810018A (en) * | 1994-12-29 | 1998-09-22 | Monte; Woodrow C. | Method, composition and apparatus for reducing the incidence of cigarette smoking |
DK0745380T3 (da) * | 1995-05-11 | 2005-12-05 | Univ Utah Res Found | Tobakserstatning |
US5955098A (en) * | 1996-04-12 | 1999-09-21 | Flemington Pharmaceutical Corp. | Buccal non polar spray or capsule |
EP0906089B1 (en) * | 1996-05-13 | 2003-08-27 | Novartis Consumer Health S.A. | Buccal delivery system |
WO2000035296A1 (en) * | 1996-11-27 | 2000-06-22 | Wm. Wrigley Jr. Company | Improved release of medicament active agents from a chewing gum coating |
EP0969733B1 (en) | 1996-11-27 | 2006-06-21 | Wm. Wrigley Jr. Company | Method of controlling release of caffeine in chewing gum and gum produced thereby |
US6413496B1 (en) * | 1996-12-04 | 2002-07-02 | Biogland Ireland (R&D) Limited | Pharmaceutical compositions and devices for their administration |
EP1107730B1 (en) * | 1998-09-03 | 2008-03-12 | Jsr Nti Llc | Medicated chewing gum delivery system for nicotine |
WO2000019977A1 (en) | 1998-10-08 | 2000-04-13 | Biovail Technologies Ltd. | Composition and method for medicated chewing gum delivery system |
US6586023B1 (en) * | 1998-12-15 | 2003-07-01 | Wm. Wrigley Jr. Company | Process for controlling release of active agents from a chewing gum coating and product thereof |
CA2366845A1 (en) | 1999-03-22 | 2000-09-28 | Atp Avant-Garde Technologies & Product Marketing & Licensing S.A. | Composition for medicated chewing gums, process for manufacturing the same and tablets so obtained |
-
2001
- 2001-06-20 SE SE0102197A patent/SE0102197D0/xx unknown
-
2002
- 2002-06-14 AT AT02744014T patent/ATE485034T1/de not_active IP Right Cessation
- 2002-06-14 BR BR0210342-7A patent/BR0210342A/pt not_active Application Discontinuation
- 2002-06-14 US US10/481,053 patent/US20040194793A1/en not_active Abandoned
- 2002-06-14 NZ NZ529780A patent/NZ529780A/en not_active IP Right Cessation
- 2002-06-14 DE DE60238054T patent/DE60238054D1/de not_active Expired - Lifetime
- 2002-06-14 IL IL15942502A patent/IL159425A0/xx active IP Right Grant
- 2002-06-14 RU RU2003137595/15A patent/RU2291688C2/ru active
- 2002-06-14 MX MXPA03011557A patent/MXPA03011557A/es active IP Right Grant
- 2002-06-14 WO PCT/SE2002/001158 patent/WO2002102357A1/en active Application Filing
- 2002-06-14 ES ES02744014T patent/ES2352681T3/es not_active Expired - Lifetime
- 2002-06-14 DK DK02744014.8T patent/DK1404306T3/da active
- 2002-06-14 AU AU2002345454A patent/AU2002345454B2/en not_active Expired
- 2002-06-14 CA CA2449298A patent/CA2449298C/en not_active Expired - Lifetime
- 2002-06-14 CZ CZ20033458A patent/CZ20033458A3/cs unknown
- 2002-06-14 JP JP2003504945A patent/JP4571402B2/ja not_active Expired - Lifetime
- 2002-06-14 EP EP02744014A patent/EP1404306B1/en not_active Expired - Lifetime
- 2002-06-19 AR ARP020102308A patent/AR034527A1/es unknown
-
2003
- 2003-11-26 ZA ZA200309204A patent/ZA200309204B/en unknown
- 2003-12-17 IL IL159425A patent/IL159425A/en unknown
-
2009
- 2009-12-24 JP JP2009293046A patent/JP2010070564A/ja active Pending
-
2011
- 2011-09-30 US US13/249,619 patent/US20120017924A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
RU2003137595A (ru) | 2005-02-10 |
JP2005500296A (ja) | 2005-01-06 |
WO2002102357A1 (en) | 2002-12-27 |
DE60238054D1 (de) | 2010-12-02 |
CA2449298C (en) | 2011-08-02 |
EP1404306A1 (en) | 2004-04-07 |
IL159425A (en) | 2006-12-10 |
AU2002345454B2 (en) | 2006-07-20 |
US20040194793A1 (en) | 2004-10-07 |
JP4571402B2 (ja) | 2010-10-27 |
RU2291688C2 (ru) | 2007-01-20 |
SE0102197D0 (sv) | 2001-06-20 |
ATE485034T1 (de) | 2010-11-15 |
ES2352681T3 (es) | 2011-02-22 |
ZA200309204B (en) | 2005-02-23 |
CZ20033458A3 (en) | 2004-05-12 |
DK1404306T3 (da) | 2011-01-24 |
AR034527A1 (es) | 2004-02-25 |
JP2010070564A (ja) | 2010-04-02 |
NZ529780A (en) | 2006-04-28 |
MXPA03011557A (es) | 2004-03-18 |
EP1404306B1 (en) | 2010-10-20 |
CA2449298A1 (en) | 2002-12-27 |
US20120017924A1 (en) | 2012-01-26 |
IL159425A0 (en) | 2004-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0210342A (pt) | Goma de mascar revestida contendo nicotina e fabricação e uso da mesma | |
AR060931A1 (es) | Producto farmaceutico recubierto para la administracion intraoral de nicotina y su uso y elaboracion | |
SE0201669D0 (sv) | New formulation and use thereof | |
EE05287B1 (et) | Tsklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon | |
DE69916486D1 (de) | Nicotin enthaltende pharmazeutische zusammensetzungen mit schneller transmukosaler absorption | |
BR0209986A (pt) | Agonista de a2a em combinação com um agente anticolinérgico, para o tratamento de doenças obstrutivas das vias respiratórias | |
ECSP099387A (es) | Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogénesis | |
DE60231835D1 (de) | Flüssige pharmazeutische zusammesetzung mit nikotin zur verabreichung in die mundhöhle | |
NZ505514A (en) | Method of manufacturing a wound dressing for the application of honey | |
MXPA05010197A (es) | Composiciones de pelicula comestible que se disuelve rapidamente con solidez y estabilidad de pelicula mejoradas. | |
CY1106574T1 (el) | Εξαφωσφορικη μυο-ινοσιτολη για τοπικη χρηση | |
BRPI0923859B8 (pt) | composição de agente de diagnóstico, e, método para a produção das nanopartículas | |
BR9914954A (pt) | Implante com cavidades contendo agentes terapêuticos | |
BR0109672A (pt) | Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente | |
BR0114927A (pt) | Composição de gel farmacêutica substancialmente não aquosa para aplicação na pele, e, uso da composição | |
ATE378058T1 (de) | Cannabis extrakten pharmazeutische zusammensetzung | |
BR0215208A (pt) | Material de enchimento de tabaco aglomerado, artigo para fumar, e, método para produzir o material de enchimento de tabaco aglomerado | |
ECSP034924A (es) | Derivados sustituidos del 1-oxa-2,8-daza-espiro[4,5]dec-2-eno | |
BR0306501A (pt) | Método para uso e produção de um tampão com medicamento | |
DE60127970D1 (de) | Zusammensetzung, welche ein antifolate und ein methylmalonsäuresenkendes mittel enthält | |
WO2005053719A3 (en) | Compositions for the treatment of diseases of the oral cavity and upper respiratory tract | |
DK1413259T3 (da) | Dental formdel, især kunstig tand | |
NZ528047A (en) | Methods and compositions for masking the taste of pharmaceutically active agents | |
ATE323464T1 (de) | Verwendung des dheas oder bestimmte seiner derivaten zur verbesserung des papyrus-ähnliches aussehens der haut | |
BR0309085A (pt) | Medicamento que contém esteróides e agente anticolinérgico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: A61K 9/68, 31/465; A61P 25/34, 43/00 Ipc: A61K 9/68 (2011.01), A61K 31/465 (2011.01), A61P 2 |
|
B15V | Prolongation of time limit allowed |
Free format text: RECONHECIDO O OBSTACULO ADMINISTRATIVO E DEVOLVIDO O PRAZO DE 30 DIAS PARA CUMPRIMENTO DE EXIGENCIA, NOS TERMOS DO ARTIGO 221 PARAGRAFO 2O DA LPI E DA RESOLUCAO 116/04. |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] |